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We examined the efficacy of a Rho kinase inhibitor, Fasudil, on cognitive impairment induced by 
chronic cerebral hypoperfusion in rats. Thirty-two male adult Sprague-Dawley rats were random-
ly divided into three groups; treated (T), control (C), and sham-operated (Sh); severe stenosis of 
the carotid arteries was modeled in the former two groups. During two weeks, 8.35 mg/kg Fasudil 
and physiological saline were i.p. applied twice per day in the T and C groups, respectively. The 
Morris water maze test was performed in each group to detect changes in the cognitive function 
and to observe pathological shifts in hippocampal morphology in rats after eight weeks. The mean 
escape latency was distinctly shorter (P < 0.01), and the percentage of swimming distance within 
the platform quadrant was significantly greater (P < 0.01) in the T group, compared to those in the 
C group at the corresponding time points. The rate of carotid artery stenosis in rats demonstrated 
no statistical difference between the T and C groups (P > 0.05). Fasudil injections effectively nor-
malized hippocampal pathomorphology in the T group. Thus, the Rho kinase inhibitor obviously 
ameliorated cognitive impairment induced by chronic cerebral hypoperfusion in rats.
Keywords: Rho kinase inhibitor, chronic cerebral hypoperfusion, hippocampus, 
cognitive impairment, water maze test.
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INTRODUCTION
It was demonstrated that stenosis of the carotid 
artery not only forms an important risk factor for 
cerebrovascular diseases, such as transient ischemic 
attack and cerebral infarction, but is also associated with 
cognitive impairment [1]. The underlying mechanism 
might be that ischemia and hypoxia cause significant 
pathological changes, including excessive production 
of free radicals, disorders of metabolism of membrane 
phospholipids in hippocampal neurons, intracellular 
calcium overload, and release of abundant amounts of 
excitatory amino acids. Finally, this results in the death 
of cholinergic neurons in the hippocampus, suppression 
of activity of choline acetyltransferase, reduced amounts 
of acetylcholine in the brain, and eventual cognitive 
impairment in patients [2]. Carotid endarterectomy 
and carotid angioplasty and stenting demonstrated 
significant positive therapeutic effects on cognitive 
impairment [3]. At the same time, carotid angioplasties 
and stenting may be related to serious complications, 
such as vasospasm, carotid artery dissection, acute stent 
thrombosis, etc. [4]. The incidence of cranial nerve 
injuries is dramatically higher at carotid endarterectomy 
than that at carotid angioplasty and stenting [5]. 
High expression and excessive activation of 
Rho kinase closely correlate with the initiation 
and development of many cardiovascular and 
cerebrovascular diseases. Rho kinase inhibitors 
provide a new hope for the treatment of diseases of 
the cardiovascular and nervous system. Shibuya et al. 
[6] discovered that a Rho kinase inhibitor, Fasudil, 
possesses an apparent efficacy with respect to cerebral 
infarction; it might modulate the processes of mig- 
ration, transformation, infiltration, and phagocytosis 
of inflammatory cells, suppressing the inflammatory 
reaction after cerebral ischemia [7]. Huang et al. [8] 
obtained certain indications that a Rho kinase inhibitor 
can improve cognitive impairment induced by chronic 
cerebral ischemia. We utilized the Rho kinase inhibitor 
to treat cognitive impairment induced by chronic 
cerebral hypoperfusion in rats and observed its efficacy, 
so as to provide a new therapy for the prevention and 
treatment of vascular cognitive impairment.
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METHODS
Animals. A total of 32 healthy male Sprague-Dawley 
(SD) rats with the body mass of 250 ± 25 g were 
provided by the Laboratory Animal Centre of the 
Medical College in the Tongji University. The animals 
were randomly divided into three groups, treated (T), 
control (C), and sham-operated (Sh) ones. There were 
12 rats in two former groups, and 8 rats in the third 
group. 
Preparation. The rat model of severe carotid artery 
stenosis was provided by constructing a stenosis in the 
carotid artery (improved-degree controllable carotid 
stenosis rat model by Zhou et al. [9]). Under ether 
inhalation anesthesia a neck midline incision was 
performed, the skin and muscles were separated, and 
the common carotid arteries (CCAs) were dissociated 
bilaterally. Syringe needles (diameter 0.45 mm) were 
tied into a slipknot at 0.5 cm from bifurcation of the 
internal and external carotid artery of the proximal 
part of CCA using #0 surgical suture soaked by 
dexamethazone. The end of the surgical suture was 
remained outside, and the needle was pulled out 
carefully. Small amounts of DXM penicillin dissolved 
in saline were dropped at the surgical field. Then the 
wound was sewed up. In the Sh group, only the CCAs 
of the rats were dissociated bilaterally. The rate of 
severe stenosis in the rat model was 70 to 99%.
Two weeks after the model was successfully 
established, 8.35 mg/kg Fasudil (Tianjin Chase Sun 
Pharmaceutical Co., Tianjin, China) suspended in 
saline was i.p administered in the T group twice per 
day for consecutive two weeks. The same volume 
of physiological saline was injected into rats of the C 
group. 
Stenosis Rate. Four rats from each group were 
anesthetized by excessive chloral hydrate and their 
CCAs were isolated and fixed in 4% paraformaldehyde. 
A stenosis site of each CCA was cut out to prepare 
cross-sectional slices. Three different sections were 
selected from the stenosis, and the stenosis area of 
each section was analyzed with a computer image 
analysis system. Then, the mean values of area the 
above for each rat were calculated.
Morris Water Maze Behavioral Test. A modified 
Morris water maze test [10] was performed in 
rats of each group before and two weeks after the 
corresponding intervention. (i) Navigation test: On the 
first day, the rat swam freely for 2 min to be adapted to 
the environment. From the second day, the rat was put 
into water and faced to the pool wall at four starting 
positions of the water pool. The route and time (escape 
latency) from putting the rat into water till it found 
a target transparent platform and climbed onto the 
latter were monitored and recorded using a computer. 
Such training was repeated four times with each rat at 
8:00 am and at 2:00 pm of each day. If any rat failed 
to locate the platform in 2 min, the latency was noted 
as equal to 2 min. The interval between two trainings 
was 60 sec long, and the total training time was for 
five days. (ii) Spatial search test: After training, the 
platform was removed on the sixth day. The rat was 
put into water and faced to the pool wall at a random 
starting position. The swimming distance between 
quadrants and traces of searching for the platform 
within 2 min were recorded.
Morphological Changes in the Hippocampus. 
After the water maze test, rats were euthanized 
by an excessive dose of chloral hydrate. The skull 
was opened to expose the hippocampus. The latter 
was isolated and fixed in 4% paraformaldehyde for 
48 h. Fixation was followed by standard dehydration, 
paraffinization, embedding, hematoxylin staining, and 
mounting. The sections were observed under a light 
microscope.
Statistical Analysis. SPSS11.0 statistical software 
was used to analyze numerical data. The latter are 
presented below as means ± s.d. Intergroup comparison 
of the mean values was performed by the t-test, and 
differences with P < 0.05 were considered significant.
RESULTS
Stenosis Rate. No carotid artery stenosis was observed 
in rats of the Sh group. The rate of carotid artery 
stenosis did not significantly decrease after treatment 
(group T), as compared to that with no treatment 
(group C, P > 0.05), which is shown in Table 1 and 
Fig. 1.
Morris Water Maze Test. The average escape 
latency was markedly longer in the C group compared 
with that in the Sh group (P < 0.01), but, after Fasudil 
injections, it was distinctly shorter in the T group 
with respect to that in the C group (P < 0.01) 
(Fig. 2).
The normalized swimming distance toward the 
platform quadrant was significantly smaller in the 
C and T groups compared with that in the Sh group 
(P < 0.01). In the T group, it became considerably 
greater two weeks after treatment than that in the C 
group (P < 0.01) (Table 2).
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F i g. 1. Cross tissue section of rat arteria carotis communis (HE staining×40). A) sham-operated group; B) control group; C) treated group. 
Р и с. 1. Перерізи загальної сонної артерії у щурів псевдооперованої, контрольної та лікованої груп (А–C відповідно).
F i g. 2. Changes in the average escape latency after treatment in 
each group (Sh, C, and T).
Р и с. 2. Зміни середніх значень латентного періоду уникання 
у різних групах. 
The experiment revealed that the normalized 
swimming distance toward the platform quadrant 
with respect to the total swimming distance was the 
biggest in Sh group, while this index in the C group 
obviously decreased, while the number of entries into 
the contralateral quadrant increased. After Fasudil 
treatment, the normalized swimming distance toward 
the platform quadrant was significantly elevated.
Morphology in the Hippocampus. In The Sh group, 
rat hippocampal neurons in alignment showed normal 
morphology, quantity, and distribution; these units 
had big and round nuclei, as well as clear nucleoli. 
At the same time rat hippocampal neurons in the 
C group were arranged in disorder. Condensed nuclei, 
their unclear structure, and disappeared nucleoli were 
observed in a part of the neurons. Rat hippocampal 
neurons were markedly ameliorated in the T group 
compared to those at corresponding time points in the 
C group (Fig. 3). 
T a b l e 2. Normalized swimming distance before and after treatment in each group (%, x ± s.d., n = 12 in the treated and control 
groups, n = 8 in the sham-operated group)
Т а б л и ц я 2. Порівняння нормованих значень відстані плавання у трьох групах перед лікуванням та після нього
Group Before treatment After treatment
Sham-operated (Sh) 67.75 ± 2.78 68.56 ± 2.32
Control (C) 36.05 ± 2.67a 30.34 ± 2.46a
Treated (T) 39.24 ± 3.67b 46.68 ± 3.67b
a: compared with the control group, P < 0.01; b: compared with the sham-operated group, P < 0.01. 
T a b l e 1. Average rates of carotid artery stenosis in differents groups of rats (%, x ± s.d., n = 12)
Т а б л и ц я 1. Середні значення ступеню стеноза сонної артерії у щурів різних груп
Group Before treatment After treatment
Sham-operated (Sh) 3.12±0.08 3.28±0.12
Control (C) 94.09±2.45 b 98.24±2.67 b
Treated (T) 95.04±2.24 b 93.20±2.21 b a
a: compared with the control group, P > 0.05; b: compared with the sham-operated group, P < 0.01.
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DISCUSSION
Vascular cognitive impairment (VCI), first described by 
Hachinski and Bowler in 1993 [11], is a term to define 
a large class of cognitive impairment syndromes, from 
mild cognitive impairment to dementia, induced by 
cerebrovascular disease-related risk factors (such as 
hypertension, diabetes, hyperlipidemia, etc.) and obvious 
(such as cerebral infarction, cerebral hemorrhage, 
etc.) or not obvious (such as leukoaraiosis and chronic 
cerebral ischemia) cerebrovascular diseases (including 
hereditary cerebrovascular ones). Sztriha et al. [12] have 
confirmed that carotid artery stenosis can cause cognitive 
impairment as an independent risk factor, which mainly 
results from thrombosis and hypoperfusion. Hojo et 
al. [13] have demonstrated that bilateral ligation of 
the common carotid arteries distinctly damages the 
cognitive function in rats; this intervention also causes 
demyelination in the white matter, reactive hyperplasia 
of glial cells, and neuronal apoptosis, which are similar 
to pathological changes in the brain of patients with VCI. 
Our research displayed that the level of cross-sectional 
area stenosis in rats in the C group was 92.09 ± 2.31%, 
on average. 
Chronic cerebral ischemia induced by severe carotid 
artery stenosis induced significant lengthening of the 
escape latency in the Morris water maze test, markedly 
decreased  the proportion of the swimming distance 
in the platform quadrant with respect to the total 
swimming distance, as well as apparently damaged 
learning and the memorial function of rats. All these 
shifts aggravated gradually along with time, indicating 
that severe carotid artery stenosis led to cognitive 
impairment and neuronal ischemia in rats determined 
by pathological changes in their CNS.
Rho-associated kinase (ROCK) is a crucial enzyme 
involved in a series of cell life phenomena, including 
adhesion of mitotic cells, cytoskeleton regulation, 
tumor cell invasion, contraction of muscle cells, etc. 
[14]. A phosphorylated adducing substrate of ROCK 
has been observed in the ischemic brain tissue by 
Yagita et al. [15] using immunohistochemical stain- 
ing; this indicates that ROCK is active in the ischemized 
brain [15]. It was demonstrated that activation of 
ROCK might be significantly involved in cognitive 
impairment induced by chronic cerebral hypoperfusion. 
The possible underlying mechanism is the following. 
Abnormally activated ROCK has adverse effects on the 
ischemic brain tissue through the following pathways: 
i) it causes vasospasm [16]; ii) it promotes thrombosis, 
affects reconstruction and restoration of neuronal 
networks, leads to oxidative stress, and promotes cell 
apoptosis [17]. 
Fasudil is a powerful ROCK inhibitor that strongly 
reduces the activity of this enzyme [18]. A number 
of studies have shown that the Rho kinase inhibitor 
plays an important role in vascular remodeling, 
improvement of blood circulation, and regulation 
of the blood pressure. It provides positive effects in 
the treatment of cardiovascular and cerebrovascular 
diseases through interaction with vasoactive 
substances, such as angiotensin II, endothelin-1, etc. 
[19]. Our results showed that Fasudil considerably 
ameliorated the impaired cognitive function and 
alleviated the level of impairment under conditions 
of chronic cerebral hypoperfusion caused by carotid 
artery stenosis in rats. This is consistent with the 
conclusions of previous studies. It was found that 
A B C
F i g. 3. Photomicrographs of hippocampal slices (HE staining, ×40). A) Sham-operated group, the morphology, number, and distribution of 
hippocampal neurons are normal, with an orderly arrangement. The cell nuclei are large and round, with clear nucleoli. B) Control group, 
hippocampal neurons are scattered and arranged disorderly. The cell structure is unclear, pyknosis occurred in some cell nuclei, and the 
nucleoli disappeared. C) Treated group, the morphology, distribution, and arrangement of hippocampal neurons were significantly improved 
compared with those in the control group.
Р и с. 3. Особливості морфології гіпокампу щурів різних груп.
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the Rho kinase inhibitor prevents the development 
of atherosclerosis. The restenosis after angioplasty 
shares similar pathological characteristics with 
atherosclerosis; therefore, the Rho kinase inhibitor 
is probably also capable of suppressing restenosis 
[20, 21]. 
The cognitive function was noticeably improved 
in treated rats. The Rho kinase inhibitor probably 
can indirectly promote the nitric oxide production, 
playing a role in antagonizing oxygen free radicals. It 
can block the metabolism of brain neurotransmitters, 
prevent certain toxic effects of harmful metabolites, 
promote neurite outgrowth, and inhibit neuronal 
apoptosis [22]. However, drug therapy provides only 
a short-term relief of clinical symptoms, which cannot 
stop the further development of pathological changes.
Recently, clinical research has shown that stent 
of the carotid artery can significantly improve 
negative shifts in cerebrovascular disease and 
cognitive impairment induced by stenosis of this 
artery. Problems related to various postoperative 
complications, such as thrombosis, cerebral ischemia, 
restenosis, hyperperfusion, and hypoperfusion need 
to be solved. Especially, restenosis after the stent 
placement seriously hinders further development 
of the technique.
Our study demonstrated that there was no signi- 
ficant change in the rate of carotid stenosis in the 
treated (T) group. Simultaneously, the Morris water 
maze test suggested that the indicators of rats were 
markedly different after treatment from those of 
control group, which indicated that Fasudil could 
distinctly ameliorate the cognitive impairment 
induced by chronic cerebral hypoperfusion in rats. In 
conclusion, Rho kinase inhibitor showed a significant 
therapeutic effect on cognitive impairment induced by 
chronic cerebral hypoperfusion.
This study was carried out in strict accordance with 
the recommendations in the Guide for the Care and Use of 
Laboratory Animals of the National Institutes of Health. The 
animal use protocol has been reviewed and approved by the 
Institutional Animal Care and Use Committee (IACUC) of the 
First Clinical Medical College.
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Р е з ю м е
Ми досліджували вплив інгібітора Rho-кінази фасудилу на 
когнітивні ураження, індуковані у щурів хронічною недо-
статністю перфузії мозку. 32 дорослі самці щурів Спрейг-
Доулі були рандомізовано поділені на три групи – “ліко-
вану” (Т), контрольну (С) та псевдооперовану (Sh); у двох 
перших групах був модельований важкий стеноз сонних ар-
терій. Протягом двох тижнів щурам груп Т і С внутрішньо-
очеревинно уводили двічі на день відповідно фасудил у дозі 
8.35 мг/кг та фізіологічний розчин. Тварини всіх груп під-
давали тесту Морріса  у водному лабіринті, щоб виявити 
зміни когнітивної функції; у цих щурів спостерігали також 
патологічні зрушення морфології гіпокампа через вісім тиж-
нів. У групі Т середній латентний період початку рухів уни-
кання ставав істотно коротшим (P < 0.01), а нормована від-
стань переміщень у квадранті з платформою була вірогідно 
більшою (P < 0.01), ніж аналогічні показники у відповідних 
часових інтервалах у групі С. Ступінь стенозу сонних арте-
рій у щурів груп Т та С не демонстрував істотних відмін-
ностей. Ін’єкції фасудилу призводили до істотної нормалі-
зації патоморфологічних зрушень у гіпокампі тварин  групи 
Т. Отже, інгібітор Rho-кінази забезпечував явне зменшення 
уражень когнітивної сфери, індукованих у щурів хронічною 
гіпоперфузією мозку.
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